00:45 , Dec 20, 2017 |  BC Extra  |  Financial News

Burroughs joins 5AM

5AM Ventures (Menlo Park, Calif.) hired Amy Burroughs as executive-in-residence. She has held several consulting and advisory positions, including strategic partner at DNA Ink (San Francisco, Calif.), since serving as chief commercial officer and head...
07:00 , Mar 25, 2013 |  BioCentury  |  Finance

Done with biotech

Done with biotech Three Arch Partners has made only a handful of biotech investments since its formation in 1993, and it is not looking for any more. The VC said last week it has no...
07:00 , Aug 23, 2010 |  BC Week In Review  |  Company News

Inspire management update

Inspire Pharmaceuticals Inc. (NASDAQ:ISPH), Durham, N.C.   Business: Ophthalmic, Pulmonary   Hired: Charles Johnson as EVP of R&D and CMO, effective Sept. 15, formerly CMO of APT Pharmaceuticals Inc.  ...
08:00 , Mar 8, 2010 |  BC Week In Review  |  Clinical News

Pulminiq: Completed Phase III enrollment

APT completed enrollment of 288 lung transplant recipients in the North American Phase III CYCLIST trial comparing standard of care immunosuppressive therapy with or without inhaled cyclosporine given thrice weekly. The company has exclusive rights...
07:00 , Oct 6, 2008 |  BC Week In Review  |  Company News

APT Pharmaceuticals board of directors update

APT Pharmaceuticals Inc. , Burlingame, Calif.   Business: Inflammation, Pulmonary, Transplant   Appointed: Bill Harrington, partner at Three Arch Partners  ...
08:00 , Dec 10, 2007 |  BC Week In Review  |  Company News

APT Pharmaceuticals board of directors update

APT Pharmaceuticals Inc. , Burlingame, Calif.   Business: Inflammation, Pulmonary, Transplant   Appointed: Paul Sekhri, president and CEO of Cerimon Pharmaceuticals Inc.  ...
08:00 , Dec 3, 2007 |  BC Week In Review  |  Company News

APT Pharmaceuticals management update

APT Pharmaceuticals Inc. , Burlingame, Calif.   Business: Inflammation, Pulmonary, Transplant   Hired: Charles Johnson as CMO, formerly VP and head of the immunology and tissue repair clinical group at Genentech Inc. ; and Amy...
07:00 , Oct 8, 2007 |  BC Week In Review  |  Company News

APT Pharmaceuticals management update

APT Pharmaceuticals Inc. , Burlingame, Calif.   Business: Inflammation, Pulmonary, Transplant   Hired: Ralph Niven as CTO, formerly SVP of preclinical development at Discovery Laboratories Inc.  ...
07:00 , Oct 8, 2007 |  BC Week In Review  |  Company News

APT Pharmaceuticals board of directors update

APT Pharmaceuticals Inc. , Burlingame, Calif.   Business: Inflammation, Pulmonary, Transplant   Appointed: Camille Samuels, managing director at Versant Ventures Management LLC; and David Kroin, managing director at Great Point Partners LLC  ...
07:00 , Jun 11, 2007 |  BC Week In Review  |  Company News

APT Pharmaceuticals, Novartis deal

APT received exclusive worldwide rights to develop and commercialize NVS's Pulminiq inhalable cyclosporine to prevent and treat lung transplant rejection. Financial terms were not disclosed. FDA issued an approvable letter for Pulminiq for the indication...